A Prospective Longitudinal Breast Cancer Study

NCT02270931 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2021-08-17

No results posted yet for this study

Summary

The purpose of this study is to obtain sufficient specimens and correlating clinical data from a well-controlled prospective clinical trial collecting longitudinal specimens from subjects diagnosed with any stage of breast cancer.

Conditions

Interventions

DEVICE

CA 15-3 Assay

Physicians use the CA 15-3 test result to manage their patients

Sponsors & Collaborators

  • Fujirebio Diagnostics, Inc.

    lead INDUSTRY

Principal Investigators

  • Diana Dickson · Fujirebio Diagnostics, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02270931 on ClinicalTrials.gov